Regulation of hepatic stellate cells by connective tissue growth factor

Frontiers in Bioscience

Volumn 17, Issue 7, 2011, Pages 2495-2507

  Huang, Guangcun ^a   Brigstock, David R ^a,b  

^a THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

CCN; CCN2; Connective tissue growth factor; CTGF; Fibrogensis; Hepatic stellate cell; Liver fibrosis; Matricellular; Review; TGF beta; Transforming growth factorbeta

Indexed keywords

ANIMALIA;

EID: 84860349542     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/4067     Document Type: Article

References (123)

1. H. Hayashi and T. Sakai: Animal models for the study of liver fibrosis: New insights from knockout mouse models. Am J Physiol Gastrointest Liver Physiol, 300, G729-38 (2011)
2. V. Hernandez-Gea and S. L. Friedman: Pathogenesis of liver fibrosis. Annu Rev Pathol, 6, 425-56 (2011)
3. Y. Lee and S. L. Friedman: Fibrosis in the liver acute protection and chronic disease. Prog Mol Biol Transl Sci, 97, 151-200 (2010)
4. M. Pinzani and J. Macias-Barragan: Update on the pathophysiology of liver fibrosis. Expert Rev Gastroenterol Hepatol, 4, 459-72 (2010)
5. S. L. Friedman: Mechanisms of hepatic fibrogenesis. Gastroenterology, 134, 1655-69 (2008) (Pubitemid 351615417)
6. J. Iredale: Defining therapeutic targets for liver fibrosis: exploiting the biology of inflammation and repair. Pharmacol Res, 58, 129-36 (2008)
7. S. L. Friedman: Stellate cells: a moving target in hepatic fibrogenesis. Hepatology, 40, 1041-3 (2004) (Pubitemid 39425557)
8. H. L. Reeves and S. L. Friedman: Activation of hepatic stellate cells-a key issue in liver fibrosis. Front Biosci, 7, d808-26 (2002)
9. A. M. Gressner, R. Weiskirchen, K. Breitkopf and S. Dooley: Roles of TGF-beta in hepatic fibrosis. Front Biosci, 7, d793-807 (2002)
10. M. Isono, M. Soda, A. Inoue, H. Akiyoshi and K. Sato: Reverse transformation of hepatic myofibroblast-like cells by TGF-beta1/LAP. Biochem Biophys Res Commun, 311, 959-65 (2003) (Pubitemid 37393412)
11. E. Albanis and S. L. Friedman: Hepatic fibrosis. Pathogenesis and principles of therapy. Clin Liver Dis, 5, 315-34, v-vi (2001) (Pubitemid 32472561)
12. P. Bedossa and V. Paradis: Transforming growth factor-beta (TGF-beta): a key-role in liver fibrogenesis. J Hepatol, 22(2 Suppl), 37-42 (1995)
13. F. Verrecchia and A. Mauviel: Transforming growth factor-beta and fibrosis. World J Gastroenterol, 13, 3056-62 (2007)
14. A. Leask and D. J. Abraham: TGF-beta signaling and the fibrotic response. FASEB J, 18, 816-27 (2004)
15. T. Gohongi, D. Fukumura, Y. Boucher, C. O. Yun, G. A. Soff, C. Compton, T. Todoroki and R. K. Jain: Tumorhost interactions in the gallbladder suppress distal angiogenesis and tumor growth: involvement of transforming growth factor-beta 1. Nat Med, 5, 1203-8 (1999) (Pubitemid 29474428)
16. M. M. Shull, I. Ormsby, A. B. Kier, S. Pawlowski, R. J. Diebold, M. Yin, R. Allen, C. Sidman, G. Proetzel, D. Calvin, N. Annunziata and T. Doetschman: Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature, 359, 693-9 (1992)
17. K. Frazier, S. Williams, D. Kothapalli, H. Klapper and G. R. Grotendorst: Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor. J Invest Dermatol, 107, 404-11 (1996) (Pubitemid 26284351)
18. A. W. Rachfal and D. R. Brigstock: Structural and functional properties of CCN proteins. Vitam Horm, 70, 69-103 (2005) (Pubitemid 43589023)
19. A. W. Rachfal and D. R. Brigstock, CCN proteins in liver injury and disease. In: CCN Proteins: A New Family of Cell Growth and Differentiation Regulators. Eds: B. Perbal and M. Takigawa. Imperial College Press, London, UK, 117-134 (2005)
20. Z. He, K. J. Way, E. Arikawa, E. Chou, D. M. Opland, A. Clermont, K. Isshiki, R. C. Ma, J. A. Scott, F. J. Schoen, E. P. Feener and G. L. King: Differential regulation of angiotensin II-induced expression of connective tissue growth factor by protein kinase C isoforms in the myocardium. J Biol Chem, 280, 15719-26 (2005) (Pubitemid 40616691)
21. X. Shi-wen, L. Kennedy, E. A. Renzoni, G. Bou-Gharios, R. M. du Bois, C. M. Black, C. P. Denton, D. J. Abraham and A. Leask: Endothelin is a downstream mediator of profibrotic responses to transforming growth factor-beta in human lung fibroblasts. Arthritis Rheum, 56, 4189-94 (2007) (Pubitemid 350262347)
22. D. R. Brigstock: The connective tissue growth factor/cysteine-rich 61/nephroblastoma overexpressed (CCN) family. Endocr Rev, 20, 189-206 (1999) (Pubitemid 29339590)
23. A. Leask and D. J. Abraham: All in the CCN family: essential matricellular signaling modulators emerge from the bunker. J Cell Sci, 119, 4803-10 (2006) (Pubitemid 46017793)
24. K. P. Holbourn, K. R. Acharya and B. Perbal: The CCN family of proteins: structure-function relationships. Trends Biochem Sci, 33, 461-73 (2008)
25. K. P. Holbourn, B. Perbal and K. Ravi Acharya: Proteins on the catwalk: modelling the structural domains of the CCN family of proteins. J Cell Commun Signal, 3, 25-41 (2009)
26. C. C. Chen and L. F. Lau: Functions and mechanisms of action of CCN matricellular proteins. Int J Biochem Cell Biol, 41, 771-83 (2009)
27. P. de Winter, P. Leoni and D. Abraham: Connective tissue growth factor: structure-function relationships of a mosaic, multifunctional protein. Growth Factors, 26, 80-91 (2008) (Pubitemid 351584060)
28. X. Shi-Wen, A. Leask and D. Abraham: Regulation and function of connective tissue growth factor/CCN2 in tissue repair, scarring and fibrosis. Cytokine Growth Factor Rev, 19, 133-44 (2008) (Pubitemid 351382279)
29. V. Paradis, D. Dargere, M. Vidaud, A. C. De Gouville, S. Huet, V. Martinez, J. M. Gauthier, N. Ba, R. Sobesky, V. Ratziu and P. Bedossa: Expression of connective tissue growth factor in experimental rat and human liver fibrosis. Hepatology, 30, 968-76 (1999) (Pubitemid 29458286)
30. E. J. Williams, M. D. Gaca, D. R. Brigstock, M. J. Arthur and R. C. Benyon: Increased expression of connective tissue growth factor in fibrotic human liver and in activated hepatic stellate cells. J Hepatol, 32, 754-61 (2000) (Pubitemid 30262735)
31. M. Abou-Shady, H. Friess, A. Zimmermann, F. F. di Mola, X. Z. Guo, H. U. Baer and M. W. Buchler: Connective tissue growth factor in human liver cirrhosis. Liver, 20, 296-304 (2000) (Pubitemid 30488001)
32. V. Paradis, G. Perlemuter, F. Bonvoust, D. Dargere, B. Parfait, M. Vidaud, M. Conti, S. Huet, N. Ba, C. Buffet and P. Bedossa: High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: a potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis. Hepatology, 34, 738-44 (2001) (Pubitemid 32927998)
33. N. Hayashi, T. Kakimuma, Y. Soma, G. R. Grotendorst, K. Tamaki, M. Harada and A. Igarashi: Connective tissue growth factor is directly related to liver fibrosis. Hepatogastroenterology, 49, 133-5 (2002) (Pubitemid 34289501)
34. K. Tsuneyama, W. Kouda and Y. Nakanuma: Portal and parenchymal alterations of the liver in idiopathic portal hypertension: a histological and immunochemical study. Pathol Res Pract, 198, 597-603 (2002) (Pubitemid 35244057)
35. A. W. Rachfal and D. R. Brigstock: Connective tissue growth factor (CTGF/CCN2) in hepatic fibrosis. 26, 1-9 (2003)
36. H. Kobayashi, N. Hayashi, K. Hayashi, A. Yamataka, G. J. Lane and T. Miyano: Connective tissue growth factor and progressive fibrosis in biliary atresia. Pediatr Surg Int, 21, 12-6 (2005) (Pubitemid 40169451)
37. S. Ozaki, Y. Sato, M. Yasoshima, K. Harada and Y. Nakanuma: Diffuse expression of heparan sulfate proteoglycan and connective tissue growth factor in fibrous septa with many mast cells relate to unresolving hepatic fibrosis of congenital hepatic fibrosis. Liver Int, 25, 817-28 (2005) (Pubitemid 41038663)
38. M. R. Narkewicz, A. Kasaragod, M. S. Lucia, S. Pflummer, R. J. Sokol and K. R. Stenmark: Connective tissue growth factor expression is increased in biliary epithelial cells in biliary atresia. J Pediatr Surg, 40, 1721-5 (2005) (Pubitemid 41625735)
39. C. Hora, F. Negro, G. Leandro, C. M. Oneta, L. Rubbia-Brandt, B. Muellhaupt, B. Helbling, R. Malinverni, J. J. Gonvers and J. F. Dufour: Connective tissue growth factor, steatosis and fibrosis in patients with chronic hepatitis C. Liver Int, 28, 370-6 (2008) (Pubitemid 351279585)
40. D. Tache, F. Bogdan, C. Pisoschi, M. Banita, C. Stanciulescu, A. M. Fusaru and V. Comanescu: Evidence for the involvement of TGF-beta 1-CTGF axis in liver fibrogenesis secondary to hepatic viral infection. Rom J Morphol Embryol, 52(1 Suppl), 409-12 (2011)
41. N. Sedlaczek, J. D. Jia, M. Bauer, H. Herbst, M. Ruehl, E. G. Hahn and D. Schuppan: Proliferating bile duct epithelial cells are a major source of connective tissue growth factor in rat biliary fibrosis. Am J Pathol, 158, 1239-44 (2001) (Pubitemid 32281287)
42. Y. Kamada, S. Tamura, S. Kiso, H. Matsumoto, Y. Saji, Y. Yoshida, K. Fukui, N. Maeda, H. Nishizawa, H. Nagaretani, Y. Okamoto, S. Kihara, J. Miyagawa, Y. Shinomura, T. Funahashi and Y. Matsuzawa: Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin. Gastroenterology, 125, 1796-807 (2003) (Pubitemid 37500444)
43. K. Uchio, M. Graham, N. M. Dean, J. Rosenbaum and A. Desmouliere: Down-regulation of connective tissue growth factor and type I collagen mRNA expression by connective tissue growth factor antisense oligonucleotide during experimental liver fibrosis. Wound Repair Regen, 12, 60-6 (2004) (Pubitemid 38249137)
44. Y. C. Hsu, Y. T. Chiu, C. Y. Lee, Y. L. Lin and Y. T. Huang: Increases in fibrosis-related gene transcripts in livers of dimethylnitrosamine-intoxicated rats. J Biomed Sci, 11, 408-17 (2004)
45. E. Ip, G. Farrell, P. Hall, G. Robertson and I. Leclercq: Administration of the potent PPAR-alpha agonist, Wy-14, 643, reverses nutritional fibrosis and steatohepatitis in mice. Hepatology, 39, 1286-96 (2004) (Pubitemid 38569050)
46. E. Biecker, A. De Gottardi, M. Neef, M. Unternahrer, V. Schneider, M. Ledermann, H. Sagesser, S. Shaw and J. Reichen: Long-term treatment of bile duct-ligated rats with rapamycin (sirolimus) significantly attenuates liver fibrosis: analysis of the underlying mechanisms. J Pharmacol Exp Ther, 313, 952-61 (2005) (Pubitemid 40726999)
47. Y. C. Hsu, Y. L. Lin, Y. T. Chiu, M. S. Shiao, C. Y. Lee and Y. T. Huang: Antifibrotic effects of Salvia miltiorrhiza on dimethylnitrosamine-intoxicated rats. J Biomed Sci, 12, 185-95 (2005)
48. G. Li, Q. Xie, Y. Shi, D. Li, M. Zhang, S. Jiang, H. Zhou, H. Lu and Y. Jin: Inhibition of connective tissue growth factor by siRNA prevents liver fibrosis in rats. J Gene Med, 8, 889-900 (2006) (Pubitemid 44097143)
49. M. Ueki, M. Koda, S. Yamamoto, Y. Matsunaga and Y. Murawaki: Preventive and therapeutic effects of angiotensin II type 1 receptor blocker on hepatic fibrosis induced by bile duct ligation in rats. J Gastroenterol, 41, 996-1004 (2006) (Pubitemid 44741413)
50. J. George and M. Tsutsumi: siRNA-mediated knockdown of connective tissue growth factor prevents Nnitrosodimethylamine-induced hepatic fibrosis in rats. Gene Ther, 14, 790-803 (2007) (Pubitemid 46706059)
51. A. Hirose, M. Ono, T. Saibara, Y. Nozaki, K. Masuda, A. Yoshioka, M. Takahashi, N. Akisawa, S. Iwasaki, J. A. Oben and S. Onishi: Angiotensin II type 1 receptor blocker inhibits fibrosis in rat nonalcoholic steatohepatitis. Hepatology, 45, 1375-81 (2007) (Pubitemid 46918321)
52. C. T. Tu, J. S. Guo, M. Wang and J. Y. Wang: Antifibrotic activity of rofecoxib in vivo is associated with reduced portal hypertension in rats with carbon tetrachloride-induced liver injury. J Gastroenterol Hepatol, 22, 877-84 (2007) (Pubitemid 46911026)
53. H. Wang, Z. Dan and H. Jiang: Effect of all-trans retinoic acid on liver fibrosis induced by common bile duct ligation in rats. J Huazhong Univ Sci Technolog Med Sci, 28, 553-7 (2008)
54. Y. M. Nan, N. Fu, W. J. Wu, B. L. Liang, R. Q. Wang, S. X. Zhao, J. M. Zhao and J. Yu: Rosiglitazone prevents nutritional fibrosis and steatohepatitis in mice. Scand J Gastroenterol, 44, 358-65 (2009)
55. J. S. Lubel, C. B. Herath, J. Tchongue, J. Grace, Z. Jia, K. Spencer, D. Casley, P. Crowley, W. Sievert, L. M. Burrell and P. W. Angus: Angiotensin-(1-7), an alternative metabolite of the renin-angiotensin system, is up-regulated in human liver disease and has antifibrotic activity in the bile-duct-ligated rat. Clin Sci (Lond), 117, 375-86 (2009)
56. T. Sugihara, M. Koda, T. Matono, K. Maeda, S. Yamamoto, M. Ueki and Y. Murawaki: Extracellular matrix metabolism-related gene expression in bile ductligated rats. Mol Med Report, 2, 345-51 (2009)
57. G. Latella, A. Vetuschi, R. Sferra, V. Catitti, A. D'Angelo, G. Zanninelli, K. C. Flanders and E. Gaudio: Targeted disruption of Smad3 confers resistance to the development of dimethylnitrosamine-induced hepatic fibrosis in mice. Liver Int, 29, 997-1009 (2009)
58. G. S. Li, W. L. Jiang, J. W. Tian, G. W. Qu, H. B. Zhu and F. H. Fu: In vitro and in vivo antifibrotic effects of rosmarinic acid on experimental liver fibrosis. Phytomedicine, 17, 282-8 (2010)
59. M. Yeki, M. Koda, T. Matono, T. Sugihara, K. Maeda and Y. Murawaki: Preventative and therapeutic effects of perindopril on hepatic fibrosis induced by bile duct ligation in rats. Mol Med Report, 2, 857-64 (2009)
60. L. Sobrevals, C. Rodriguez, J. L. Romero-Trevejo, G. Gondi, I. Monreal, A. Paneda, N. Juanarena, S. Arcelus, N. Razquin, L. Guembe, G. Gonzalez-Aseguinolaza, J. Prieto and P. Fortes: Insulin-like growth factor I gene transfer to cirrhotic liver induces fibrolysis and reduces fibrogenesis leading to cirrhosis reversion in rats. Hepatology, 51, 912-21 (2010)
61. C. S. Lim, E. Y. Kim, H. S. Lee, Y. Soh, Y. Sohn, S. Y. Kim, N. W. Sohn, H. S. Jung and Y. B. Kim: Protective effects of Cinnamomum cassia Blume in the fibrogenesis of activated HSC-T6 cells and dimethylnitrosamine-induced acute liver injury in SD rats. Biosci Biotechnol Biochem, 74, 477-83 (2010)
62. J. Hou, J. Tian, W. Jiang, Y. Gao and F. Fu: Therapeutic effects of SMND-309, a new metabolite of salvianolic acid B, on experimental liver fibrosis. Eur J Pharmacol, 650, 390-5 (2011)
63. J. H. Wang, J. W. Shin, M. K. Choi, H. G. Kim and C. G. Son: An herbal fruit, Amomum xanthoides, ameliorates thioacetamide-induced hepatic fibrosis in rat via antioxidative system. J Ethnopharmacol, 135, 344-50 (2011)
64. K. E. Nakken, S. Nygard, T. Haaland, K. E. Berge, K. Arnkvaern, A. Odegaard, K. J. Labori and M. G. Raeder: Multiple inflammatory-, tissue remodelling-and fibrosis genes are differentially transcribed in the livers of Abcb4 (-/ -) mice harbouring chronic cholangitis. Scand J Gastroenterol, 42, 1245-55 (2007) (Pubitemid 47537083)
65. A. Rullier, J. Gillibert-Duplantier, P. Costet, G. Cubel, V. Haurie, C. Petibois, D. Taras, N. Dugot-Senant, G. Deleris, P. Bioulac-Sage and J. Rosenbaum: Proteaseactivated receptor 1 knockout reduces experimentally induced liver fibrosis. Am J Physiol Gastrointest Liver Physiol, 294, G226-35 (2008) (Pubitemid 351164861)
66. T. Tamatani, H. Kobayashi, K. Tezuka, S. Sakamoto, K. Suzuki, T. Nakanishi, M. Takigawa and T. Miyano: Establishment of the enzyme-linked immunosorbent assay for connective tissue growth factor (CTGF) and its detection in the sera of biliary atresia. Biochem Biophys Res Commun, 251, 748-52 (1998) (Pubitemid 28512782)
67. A. M. Gressner, E. Yagmur, B. Lahme, O. Gressner and S. Stanzel: Connective tissue growth factor in serum as a new candidate test for assessment of hepatic fibrosis. Clin Chem, 52, 1815-7 (2006) (Pubitemid 44330719)
68. W. Guo-Qiu, L. Nai-Feng, V. Xiao-Bo, L. Linxian, Z. Chen, G. Lixia and L. Zhao: The level of connective tissue growth factor in sera of patients with hepatitis B virus strongly correlates with stage of hepatic fibrosis. Viral Immunol, 23, 71-8 (2010)
69. E. Kovalenko, F. Tacke, O. A. Gressner, H. W. Zimmermann, B. Lahme, A. Janetzko, T. Wiederholt, T. Berg, T. Muller, C. Trautwein, A. M. Gressner and R. Weiskirchen: Validation of connective tissue growth factor (CTGF/CCN2) and its gene polymorphisms as noninvasive biomarkers for the assessment of liver fibrosis. J Viral Hepat, 16, 612-20 (2009)
70. D. Zhang, N. Y. Wang, C. B. Yang, G. X. Fang, W. Liu, J. Wen and C. Luo: The clinical value of serum connective tissue growth factor in the assessment of liver fibrosis. Dig Dis Sci, 55, 767-74 (2010)
71. A. Haafiz, C. Farrington, J. Andres and S. Islam: Relationship between hepatic CTGF expression and routine blood tests at the time of liver transplantation for biliary atresia: hope or hype for a biomarker of hepatic fibrosis. Clin Exp Gastroenterol, 4, 49-54 (2011)
72. G. B. Wang, X. Y. Zhou, T. Yuan, J. Xie, L. P. Guo, N. Gao and X. Q. Wang: Significance of serum connective tissue growth factor in patients with hepatocellular carcinoma and relationship with angiogenesis. World J Surg, 34, 2411-7 (2010)
73. L. Chen, A. L. Charrier, A. Leask, S. W. French and D. R. Brigstock: Ethanol-stimulated differentiated functions of human or mouse hepatic stellate cells are mediated by connective tissue growth factor. J Hepatol , 55, 399-406 (2010)
74. Z. Tong, R. Chen, D. S. Alt, S. Kemper, B. Perbal and D. R. Brigstock: Susceptibility to liver fibrosis in mice expressing a connective tissue growth factor transgene in hepatocytes. Hepatology, 50, 939-47 (2009)
75. J. Y. Shin, W. Hur, J. S. Wang, J. W. Jang, C. W. Kim, S. H. Bae, S. K. Jang, S. H. Yang, Y. C. Sung, O. J. Kwon and S. K. Yoon: HCV core protein promotes liver fibrogenesis via up-regulation of CTGF with TGF-beta 1. Exp Mol Med, 37, 138-45 (2005) (Pubitemid 40676924)
76. S. Martin-Vilchez, P. Sanz-Cameno, Y. Rodriguez-Munoz, P. L. Majano, F. Molina-Jimenez, M. Lopez-Cabrera, R. Moreno-Otero and E. Lara-Pezzi: The hepatitis B virus X protein induces paracrine activation of human hepatic stellate cells. Hepatology, 47, 1872-83 (2008) (Pubitemid 351945555)
77. J. Wang, I. Leclercq, J. M. Brymora, N. Xu, M. Ramezani-Moghadam, R. M. London, D. Brigstock and J. George: Kupffer cells mediate leptin-induced liver fibrosis. Gastroenterology, 137, 713-23 (2009)
78. L. Pi, S. H. Oh, T. Shupe and B. E. Petersen: Role of connective tissue growth factor in oval cell response during liver regeneration after 2-AAF/PHx in rats. Gastroenterology, 128, 2077-88 (2005) (Pubitemid 40824715)
79. K. Ujike, T. Shinji, S. Hirasaki, H. Shiraha, M. Nakamura, T. Tsuji and N. Koide: Kinetics of expression of connective tissue growth factor gene during liver regeneration after partial hepatectomy and Dgalactosamine-induced liver injury in rats. Biochem Biophys Res Commun, 277, 448-54 (2000)
80. D. R. Brigstock: Regulation of angiogenesis and endothelial cell function by connective tissue growth factor (CTGF) and cysteine-rich 61 (CYR61). Angiogenesis, 5, 153-65 (2002) (Pubitemid 36687518)
81. S. Chujo, F. Shirasaki, M. Kondo-Miyazaki, Y. Ikawa and K. Takehara: Role of connective tissue growth factor and its interaction with basic fibroblast growth factor and macrophage chemoattractant protein-1 in skin fibrosis. J Cell Physiol, 220, 189-95 (2009)
82. A. Seher, J. Nickel, T. D. Mueller, S. Kneitz, S. Gebhardt, T. M. ter Vehn, G. Schlunck and W. Sebald: Gene expression profiling of connective tissue growth factor (CTGF) stimulated primary human tenon fibroblasts reveals an inflammatory and wound healing response in vitro. Mol Vis, 17, 53-62 (2011)
83. O. A. Gressner, I. Peredniene and A. M. Gressner: Connective tissue growth factor reacts as an IL-6/STAT3-regulated hepatic negative acute phase protein. World J Gastroenterol, 17, 151-63 (2011)
84. L. Kular, J. Pakradouni, P. Kitabgi, M. Laurent and C. Martinerie: The CCN family: a new class of inflammation modulators? Biochimie, 93(3), 377-88 (2011)
85. R. Gao and D. R. Brigstock: Low density lipoprotein receptor-related protein (LRP) is a heparin-dependent adhesion receptor for connective tissue growth factor (CTGF) in rat activated hepatic stellate cells. Hepatol Res, 27, 214-220 (2003) (Pubitemid 37407669)
86. G. Huang and D. R. Brigstock: Integrin expression and function in the response of primary culture hepatic stellate cells to connective tissue growth factor (CCN2). J Cell Mol Med, 15, 1087-1095 (2011)
87. R. Gao, D. K. Ball, B. Perbal and D. R. Brigstock: Connective tissue growth factor induces c-fos gene activation and cell proliferation through p44/42 MAP kinase in primary rat hepatic stellate cells. J Hepatol, 40, 431-8 (2004) (Pubitemid 38230844)
88. A. Leask, S. Chen, D. Pala and D. R. Brigstock: Regulation of CCN2 mRNA expression and promoter activity in activated hepatic stellate cells. J Cell Commun Signal, 2, 49-56 (2008)
89. G. H. Guo, D. M. Tan, P. A. Zhu and F. Liu: Hepatitis B virus X protein promotes proliferation and upregulates TGFbeta 1 and CTGF in human hepatic stellate cell line, LX-2. Hepatobiliary Pancreat Dis Int, 8, 59-64 (2009)
90. Y. Liu, C. Meyer, A. Muller, F. Herweck, Q. Li, R. Mullenbach, P. R. Mertens, S. Dooley and H. L. Weng: IL-13 induces connective tissue growth factor in rat hepatic stellate cells via TGF-beta-independent Smad signaling. J Immunol, 187, 2814-23 (2011)
91. M. J. Perugorria, M. U. Latasa, A. Nicou, H. Cartagena-Lirola, J. Castillo, S. Goni, U. Vespasiani-Gentilucci, M. G. Zagami, S. Lotersztajn, J. Prieto, C. Berasain and M. A. Avila: The epidermal growth factor receptor ligand amphiregulin participates in the development of mouse liver fibrosis. Hepatology, 48, 1251-61 (2008)
92. V. Paradis, D. Dargere, F. Bonvoust, M. Vidaud, P. Segarini and P. Bedossa: Effects and regulation of connective tissue growth factor on hepatic stellate cells. Lab Invest, 82, 767-74 (2002)
93. G. Son, I. N. Hines, J. Lindquist, L. W. Schrum and R. A. Rippe: Inhibition of phosphatidylinositol 3-kinase signaling in hepatic stellate cells blocks the progression of hepatic fibrosis. Hepatology, 50, 1512-23 (2009)
94. R. Gao and D. R. Brigstock: Connective tissue growth factor (CCN2) induces adhesion of rat activated hepatic stellate cells by binding of its C-terminal domain to integrin alpha(v)beta(3) and heparan sulfate proteoglycan. J Biol Chem, 279, 8848-55 (2004) (Pubitemid 38295943)
95. Z. Y. Tong and D. R. Brigstock: Intrinsic biological activity of the thrombospondin structural homology repeat in connective tissue growth factor. J Endocrinol, 188, R1-8 (2006)
96. L. F. Lau: CCN1/CYR61: the very model of a modern matricellular protein. Cell Mol Life Sci (2011)
97. L. Pi, X. Ding, M. Jorgensen, J. J. Pan, S. H. Oh, D. Pintilie, A. Brown, W. Y. Song and B. E. Petersen: Connective tissue growth factor with a novel fibronectin binding site promotes cell adhesion and migration during rat oval cell activation. Hepatology, 47, 996-1004 (2008) (Pubitemid 351449691)
98. Y. Chen, D. J. Abraham, X. Shi-Wen, J. D. Pearson, C. M. Black, K. M. Lyons and A. Leask: CCN2 (connective tissue growth factor) promotes fibroblast adhesion to fibronectin. Mol Biol Cell, 15, 5635-46 (2004) (Pubitemid 39564754)
99. M. Hoshijima, T. Hattori, M. Inoue, D. Araki, H. Hanagata, A. Miyauchi and M. Takigawa: CT domain of CCN2/CTGF directly interacts with fibronectin and enhances cell adhesion of chondrocytes through integrin alpha 5 beta 1. FEBS Lett, 580, 1376-82 (2006) (Pubitemid 43222004)
100. C. A. Droppelmann, J. Gutierrez, C. Vial and E. Brandan: Matrix metalloproteinase-2-deficient fibroblasts exhibit an alteration in the fibrotic response to connective tissue growth factor/CCN2 because of an increase in the levels of endogenous fibronectin. J Biol Chem, 284, 13551-61 (2009)
101. Y. Chen, P. Segarini, F. Raoufi, D. Bradham and A. Leask: Connective tissue growth factor is secreted through the Golgi and is degraded in the endosome. Exp Cell Res, 271, 109-17 (2001) (Pubitemid 33070998)
102. R. Gao and D. R. Brigstock: Activation of nuclear factor kappa B (NF-kappaB) by connective tissue growth factor (CCN2) is involved in sustaining the survival of primary rat hepatic stellate cells. Cell Commun Signal, 3, 14 (2005)
103. X. Zhou, F. R. Murphy, N. Gehdu, J. Zhang, J. P. Iredale and R. C. Benyon: Engagement of alpha v beta 3 integrin regulates proliferation and apoptosis of hepatic stellate cells. J Biol Chem, 279, 23996-4006 (2004) (Pubitemid 38725258)
104. D. R. Brigstock, C. L. Steffen, G. Y. Kim, R. K. Vegunta, J. R. Diehl and P. A. Harding: Purification and characterization of novel heparin-binding growth factors in uterine secretory fluids. Identification as heparin-regulated Mr 10, 000 forms of connective tissue growth factor. J Biol Chem, 272, 20275-82 (1997) (Pubitemid 27340141)
105. D. K. Ball, E. E. Moussad, M. A. Rageh, S. A. Kemper and D. R. Brigstock: Establishment of a recombinant expression system for connective tissue growth factor (CTGF) that models CTGF processing in utero. Reproduction, 125, 271-84 (2003) (Pubitemid 36284899)
106. R. A. Dean, G. S. Butler, Y. Hamma-Kourbali, J. Delbe, D. R. Brigstock, J. Courty and C. M. Overall: Identification of candidate angiogenic inhibitors processed by matrix metalloproteinase 2 (MMP-2) in cell-based proteomic screens: disruption of vascular endothelial growth factor (VEGF)/heparin affin regulatory peptide (pleiotrophin) and VEGF/Connective tissue growth factor angiogenic inhibitory complexes by MMP-2 proteolysis. Mol Cell Biol, 27, 8454-65 (2007)
107. D. R. Brigstock: Connective tissue growth factor (CCN2, CTGF) and organ fibrosis: lessons from transgenic animals. J Cell Commun Signal, 4, 1-4 (2010)
108. T. Mori, S. Kawara, M. Shinozaki, N. Hayashi, T. Kakinuma, A. Igarashi, M. Takigawa, T. Nakanishi and K. Takehara: Role and interaction of connective tissue growth factor with transforming growth factor-beta in persistent fibrosis: A mouse fibrosis model. J Cell Physiol, 181, 153-9 (1999) (Pubitemid 29400382)
109. Q. Wang, W. Usinger, B. Nichols, J. Gray, L. Xu, T. W. Seeley, M. Brenner, G. Guo, W. Zhang, N. Oliver, A. Lin and D. Yeowell: Cooperative interaction of CTGF and TGF-beta in animal models of fibrotic disease. Fibrogenesis Tissue Repair, 4, 4 (2011)
110. J. G. Abreu, N. I. Ketpura, B. Reversade and E. M. De Robertis: Connective tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta. Nat Cell Biol, 4, 599-604 (2002)
111. T. Matono, M. Koda, S. Tokunaga, T. Sugihara, M. Ueki and Y. Murawaki: The effects of the selective mineralocorticoid receptor antagonist eplerenone on hepatic fibrosis induced by bile duct ligation in rat. Int J Mol Med, 25, 875-82 (2010)
112. N. Kurikawa, M. Suga, S. Kuroda, K. Yamada and H. Ishikawa: An angiotensin II type 1 receptor antagonist, olmesartan medoxomil, improves experimental liver fibrosis by suppression of proliferation and collagen synthesis in activated hepatic stellate cells. Br J Pharmacol, 139, 1085-94 (2003) (Pubitemid 36920670)
113. F. Yumei, Y. Zhou, S. Zheng and A. Chen: The antifibrogenic effect of (-)-epigallocatechin gallate results from the induction of de novo synthesis of glutathione in passaged rat hepatic stellate cells. Lab Invest, 86, 697-709 (2006) (Pubitemid 43901667)
114. C. Zhang, Y. Zhu, J. Wan, H. Xu, H. Shi and X. Lu: Effects of Ginkgo biloba extract on cell proliferation, cytokines and extracellular matrix of hepatic stellate cells. Liver Int, 26, 1283-90 (2006) (Pubitemid 44741216)
115. X. D. Wang, Z. H. Gao, X. Xue, Y. N. Cheng, P. Yue, X. W. Fang and X. J. Qu: N1-acetyl substituted pyrrolidine derivative CIP-A5: a novel compound that could ameliorate liver cirrhosis through modulation of hepatic stellate cell activity. Toxicol In vitro, 25, 897-904 (2011)
116. K. Sun, Q. Wang and X. H. Huang: PPAR gamma inhibits growth of rat hepatic stellate cells and TGF-betainduced connective tissue growth factor expression. Acta Pharmacol Sin, 27, 715-23 (2006) (Pubitemid 43943920)
117. S. Zheng and A. Chen: Curcumin suppresses the expression of extracellular matrix genes in activated hepatic stellate cells by inhibiting gene expression of connective tissue growth factor. Am J Physiol Gastrointest Liver Physiol, 290, G883-93 (2006)
118. J. Xu, Y. Fu and A. Chen: Activation of peroxisome proliferator-activated receptor-gamma contributes to the inhibitory effects of curcumin on rat hepatic stellate cell growth. Am J Physiol Gastrointest Liver Physiol, 285, G20-30 (2003) (Pubitemid 36736384)
119. A. Chen and S. Zheng: Curcumin inhibits connective tissue growth factor gene expression in activated hepatic stellate cells in vitro by blocking NF-kappaB and ERK signalling. Br J Pharmacol, 153, 557-67 (2008) (Pubitemid 351199009)
120. G. Li, D. Li, Q. Xie, Y. Shi, S. Jiang and Y. Jin: RNA interfering connective tissue growth factor prevents rat hepatic stellate cell activation and extracellular matrix production. J Gene Med, 10, 1039-47 (2008)
121. Z. Yuhua, R. Wanhua, S. Chenggang, S. Jun, W. Yanjun and Z. Chunqing: Disruption of connective tissue growth factor by short hairpin RNA inhibits collagen synthesis and extracellular matrix secretion in hepatic stellate cells. Liver Int, 28, 632-9 (2008) (Pubitemid 351541094)
122. R. P. Gao and D. R. Brigstock: Connective tissue growth factor hammerhead ribozyme attenuates human hepatic stellate cell function. World J Gastroenterol, 15, 3807-13 (2009)
123. D. R. Brigstock: Strategies for blocking the fibrogenic actions of connective tissue growth factor (CCN2): From pharmacological inhibition in vitro to targeted siRNA therapy in vivo. J Cell Commun Signal, 3, 5-18 (2009)